Solid basal adenoid cystic carcinoma of the breast: A case report and literature review

Wen Bin Gou,Yong Qiang Yang,Bei Wen Song,Pei He
DOI: https://doi.org/10.1097/md.0000000000037010
IF: 1.6
2024-01-20
Medicine
Abstract:Adenoid cystic carcinoma (AdCC) is a rare malignant tumor of the breast, accounting for 0.1% to 3.5% of all breast tumors. Breast AdCC is a specific subtype of triple-negative breast cancer (TNBC) and its histological presentation is different from that of invasive ductal carcinoma. [ 1–5 ] However, it has a better prognosis than the other subtypes, with 5-, 10- and 15-year survival rates reaching 98.1%, 94.9%, and 91.4%, respectively. [ 6 ] The fifth edition of the WHO guide classifies AdCC into 3 categories: classic AdCC (C-AdCC), solid basaloid AdCC (SB-AdCC), and AdCC with high-grade transformation. [ 7 ] SB-AdCC is usually characterized by solid nests composed of basal-like cells with obvious atypia, frequent mitotic figures, and visible necrosis. Due to its rarity, it is urgently needed to report new cases of SB-ADCC in order to improve the level of diagnosis and treatment of the disease. Here we report a case of SB-AdCC of the breast with detailed clinical, histological, and immunohistochemical, including the FISH detection of MYB gene-break.
medicine, general & internal
What problem does this paper attempt to address?